McDonnell Boehnen Hulbert & Berghoff LLP is proud to be an official sponsor of the 2014 North Carolina Biosciences Organization (NCBIO) Annual Meeting set for October 16 from 8:00 a.m. to 1:00 p.m. at the NC Biotechnology Center in Research Triangle Park, NC. The event will feature panels on “bench to market” lessons learned by both biopharma and medical devices companies, current federal policy issues from NCBIO partners, BIO, AdvaMed, and CropLife America, an update from the NC Office of Science, Technology and Innovation, and a keynote address from RJ Kirk, Chairman and CEO of Intrexon. Attendees will consist of North Carolina life science industry leaders, executives, and policy makers.
The North Carolina Biosciences Organization (NCBIO) is the trade association for North Carolina’s life science community. As a statewide nonprofit advocacy organization, NCBIO works with federal, state and local officials to improve North Carolina’s attractiveness as a location for life science discovery, innovation and commercialization. NCBIO also provides a variety of membership benefits designed to directly support the growth of its member companies and institutions, which are part of the nation’s third largest state biotechnology cluster. NCBIO’s members include companies and institutions from all sectors of North Carolina’s life science industry.
View complete details at http://ncbioscience.net/default.aspx.